FDA Says Columbia Labs' (CBRX) Preterm Birth Gel Not Effective -Bloomberg

Shares of Columbia Labs (Nasdaq: CBRX) falling as Bloomberg reporting the FDA has posted documents for its January 20th meeting on the company's preterm birth gel. The FDA is saying the product is not effective.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Acrivon Therapeutics (ACRV) Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event
• Rimini Street (RMNI) Appoints Steve Hershkowitz as Chief Revenue Officer
• Canadian Pacific Kansas City (CP) Announces Results of Board Elections